semaglutide off shortage list is on the As of February 21, 2025, the FDA updated its drug FDA Declares Shortage of Novo

Our goal at Rivas Medical Weight Loss is to provide our patients with the tools and information to achieve a reduced weight and maintain the loss long term

Understanding how peptides work at the molecular level helps you appreciate why storage guidelines exist and why they include built-in safety margins

Understanding proper injection anatomy is essential for safe, reliable treatment

Use of GLP-1 analogue drugs is associated with benefits but also health risks The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension